Skip to main content

Accolade, Inc. (ACCD)

NASDAQ: ACCD · IEX Real-Time Price · USD
43.57
+0.51 (1.18%)
After-hours:Sep 24, 2021 6:37 PM EDT
43.06
-1.27 (-2.86%)
At close: Sep 24, 4:00 PM
Market Cap2.85B
Revenue (ttm)193.99M
Net Income (ttm)-85.40M
Shares Out66.07M
EPS (ttm)-2.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume232,772
Open43.85
Previous Close44.33
Day's Range42.68 - 44.33
52-Week Range32.87 - 65.25
Betan/a
AnalystsStrong Buy
Price Target61.90 (+43.8%)
Est. Earnings DateOct 7, 2021

About ACCD

Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees ...

IndustryHealth Care Technology
IPO DateJul 2, 2020
Employees1,900
Stock ExchangeNASDAQ
Ticker SymbolACCD
Full Company Profile

Financial Performance

In 2020, Accolade's revenue was $170.36 million, an increase of 28.57% compared to the previous year's $132.51 million. Losses were -$50.65 million, -1.39% less than in 2019.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for Accolade stock is "Strong Buy." The 12-month stock price forecast is 61.90, which is an increase of 43.75% from the latest price.

Price Target
$61.90
(43.75% upside)
Analyst Consensus: Strong Buy

News

Accolade doubles down on personalized mental health services with new offerings

Health benefits platform company Accolade is expanding its offerings to add two personalized services with an emphasis on mental health, the company announced Tuesday.

4 days ago - GeekWire

Accolade introduces new healthcare category: Personalized Healthcare

SEATTLE, Sept. 21, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, today introduced Personalized Healthca...

5 days ago - PRNewsWire

Accolade Invites Media, Investors and General Public to Opening of Evolve21

SEATTLE, Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare will be making an anno...

6 days ago - PRNewsWire

Accolade to Participate in Upcoming Investor Conferences

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming in...

2 weeks ago - GlobeNewsWire

New Strong Sell Stocks for August 17th

ACCD, CHRS, ELVT, FLGT, and GSHD have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2021.

Other symbols:CHRSELVTFLGTGSHD
1 month ago - Zacks Investment Research

Accolade to Participate in the 41st Annual Canaccord Genuity Growth Conference

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord ...

1 month ago - GlobeNewsWire

New Strong Sell Stocks for July 12th

ACCD, CMTL, HEXO, NTRB, and GP have been added to the Zacks Rank #5 (Strong Sell) List on July 12, 2021

Other symbols:CMTLGPHEXONTRB
2 months ago - Zacks Investment Research

Accolade Announces Results for Fiscal First Quarter 2022

SEATTLE, July 08, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced financial results for the fisc...

2 months ago - GlobeNewsWire

New Strong Sell Stocks for July 7th

ACCD, DNLI, FSLY, FHB and GH have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2021.

Other symbols:DNLIFHBFSLYGH
2 months ago - Zacks Investment Research

Will Accolade (ACCD) Report Negative Earnings Next Week? What You Should Know

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Accolade to Announce Fiscal First Quarter 2022 Financial Results

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal fi...

3 months ago - GlobeNewsWire

Accolade Completes Acquisition of PlushCare

SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has completed the acquisiti...

3 months ago - GlobeNewsWire

Acco Brands Corp And Malibu Boats Inc Among Today's Top Buys

The Dow Jones rose 40 points, while both the S&P 500 and Nasdaq traded flat. Make the most of this market with today's top buys from Q.ai's artificial intelligence.

Other symbols:MBUUMKSITTECWSM
3 months ago - Forbes

Booming Telehealth Market Lures More IPOs and M&A Deals

To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions.

Other symbols:AMWLGDRXTDOCTLMD
3 months ago - Zacks Investment Research

Betsy Nabel and Jeff Brodsky join Accolade Board of Directors

SEATTLE, June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with signific...

3 months ago - PRNewsWire

Accolade to Participate in Upcoming Investor Conferences

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming inv...

3 months ago - GlobeNewsWire

New Strong Sell Stocks for May 17th

ACCD, CEVA, FCEL, GO, and IIPR have been added to the Zacks Rank #5 (Strong Sell) List on May 17, 2021

Other symbols:CEVAFCELGOIIPR
4 months ago - Zacks Investment Research

CORRECTION -- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021

SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Accolade, Inc. (NASDAQ: ACCD) please note that the entire Consolidated Statements of Operations (un...

4 months ago - GlobeNewsWire

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021

SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced financial results for the fisca...

4 months ago - GlobeNewsWire

Health benefits platform Accolade to acquire virtual primary care startup PlushCare in $450M deal

The news: Seattle-based health benefits platform Accolade will pay up to $450 million to acquire PlushCare, a Bay Area-based startup that offers virtual primary care.

5 months ago - GeekWire

Accolade to Acquire PlushCare

SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has signed a definitive ag...

5 months ago - GlobeNewsWire

Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering

SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “N...

6 months ago - GlobeNewsWire

Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021

SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021 (fiscal ye...

6 months ago - GlobeNewsWire

Accolade Announces Private Offering of $250 Million Convertible Notes

SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal ...

6 months ago - GlobeNewsWire

Accolade To Buy 2nd.MD To Boost Telehealth Options

Healthcare technology company Accolade is buying telemedicine startup 2nd.MD to boost its abilities to help users navigate medical plans and second options, CNBC reported. The sale is likely to go forwa...

8 months ago - PYMNTS